Galmed Pharmaceuticals Ltd. diskutieren
Galmed Pharmaceuticals Ltd.
WKN: A1XFUX / Symbol: GMED / Name: Galmed Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
6,40 €
4,84 %
Globus Medical (NYSE:GMED) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for GMED provided by MarketBeat
Globus Medical (NYSE:GMED) had its price target raised by analysts at Royal Bank Of Canada from $92.00 to $100.00. They now have an "outperform" rating on the stock.
Ratings data for GMED provided by MarketBeat
Globus Medical (NYSE:GMED) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Globus Medical (GMED) had its price target raised by Needham & Company LLC from $112.00 to $114.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Globus Medical (GMED) had its price target raised by Barclays PLC from $118.00 to $123.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
Globus Medical (GMED) had its price target raised by Wells Fargo & Company from $98.00 to $104.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
Neueste Beiträge
DA_Davidson in Trade Desk Inc diskutieren